Zura Bio (NASDAQ:ZURA) Azioni, Quote.MetaTitle.unusual-options

Zura Bio

Zura Bio Limited - Class A Ordinary shares

Zura Bio Ltd

AC Immune

Aldeyra Therapeutics, Inc. - Common Stock

Aldeyra Therapeutics

Allogene Therapeutics, Inc. - Common Stock

Allogene Therapeutics

Amarin Corporation plc - American Depositary Shares

Amarin Corp

Annexon

Avalo Therapeutics

Black Diamond Therapeutics, Inc. - Common Stock

Black Diamond Therapeutic

Candel Therapeutics

Capricor Therapeutics, Inc. - Common Stock

Capricor Therapeutics

DiaMedica Therapeutics Inc. - Common Stock

DiaMedica Therapeutics

Editas Medicine

Enanta Pharmaceuticals, Inc. - Common Stock

Enanta Pharma

Eupraxia Pharmaceuticals Inc. - Common Stock

Eupraxia Pharmaceuticals

ETHZilla

Korro Bio

Kyverna Therapeutics, Inc. - Common Stock

Kyverna Therapeutics

Larimar Therapeutics, Inc. - Common Stock

Larimar Therapeutics

Lyell Immunopharma

Mereo BioPharma Group plc - American Depositary Shares

Mereo BioPharma Group

Palisade Bio

Pyxis Oncology

Sagimet Biosciences Inc. - Series A Common Stock

Sagimet Biosciences

Silence Therapeutics Plc - American Depository Share

Silence Therapeutics

Entrada Therapeutics, Inc. - Common Stock

Entrada Therapeutics

X4 Pharmaceuticals

Zura Bio (ZURA) Previsione

Notizie

Utili

Quote.Nav.option-chain

Valutazioni degli analisti

Insider trading

Vendite allo scoperto

Rapporto azionario

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

Comments

Zura Bio Opzioni Inusuali

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO